BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16885671)

  • 21. Premature rupture of membranes at term with an unfavorable cervix: comparison of expectant management, vaginal prostaglandin, and oxytocin induction.
    McCaul JF; Rogers LW; Perry KG; Martin RW; Allbert JR; Morrison JC
    South Med J; 1997 Dec; 90(12):1229-33. PubMed ID: 9404911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EFFECTIVENESS AND SAFETY OF 2-HOURLY 20 MCG ORAL MISOPROSTOL SOLUTION COMPARED TO STANDARD INTRAVENOUS OXYTOCIN IN LABOUR INDUCTION DUE TO PRE-LABOUR RUPTURE OF MEMBRANES AT TERM: A RANDOMISED CLINICAL TRIAL AT KENYATTA NATIONAL HOSPITAL.
    Mbaluka CM; Kamau K; Karanja JG; Mugo N
    East Afr Med J; 2014 Sep; 91(9):303-10. PubMed ID: 26866082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Planned early birth vs. expectant management for PROM.
    Rosen R
    Am Fam Physician; 2006 Jul; 74(1):79-80. PubMed ID: 16850550
    [No Abstract]   [Full Text] [Related]  

  • 24. Misoprostol for labor induction in women with term premature rupture of membranes: a meta-analysis.
    Lin MG; Nuthalapaty FS; Carver AR; Case AS; Ramsey PS
    Obstet Gynecol; 2005 Sep; 106(3):593-601. PubMed ID: 16135593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostaglandin gel versus oxytocin - prelabour rupture of membranes at term - A randomised controlled trial.
    Mahomed K; Wild K; Weekes CR
    Aust N Z J Obstet Gynaecol; 2018 Dec; 58(6):654-659. PubMed ID: 29468633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral misoprostol for induction of labor in prelabor rupture of membranes (PROM) at term: a randomized control trial.
    Cheung PC; Yeo EL; Wong KS; Tang LC
    Acta Obstet Gynecol Scand; 2006; 85(9):1128-33. PubMed ID: 16929421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The MisoPROM study: a multicenter randomized comparison of oral misoprostol and oxytocin for premature rupture of membranes at term.
    Mozurkewich E; Horrocks J; Daley S; Von Oeyen P; Halvorson M; Johnson M; Zaretsky M; Tehranifar M; Bayer-Zwirello L; Robichaux A; Droste S; Turner G;
    Am J Obstet Gynecol; 2003 Oct; 189(4):1026-30. PubMed ID: 14586349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral misoprostol vs. intravenous oxytocin for labor induction in women with prelabor rupture of membranes at term.
    Al-Hussaini TK; Abdel-Aal SA; Youssef MA
    Int J Gynaecol Obstet; 2003 Jul; 82(1):73-5. PubMed ID: 12834947
    [No Abstract]   [Full Text] [Related]  

  • 29. A randomized trial of Foley Bulb for Labor Induction in Premature Rupture of Membranes in Nulliparas (FLIP).
    Amorosa JMH; Stone J; Factor SH; Booker W; Newland M; Bianco A
    Am J Obstet Gynecol; 2017 Sep; 217(3):360.e1-360.e7. PubMed ID: 28479288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sublingual Misoprostol versus Oxytocin to Induce Labor in Term Premature Rupture of Membranes in Pregnant Women: A Randomized Single-Blind Controlled Trial.
    Unthanan S; Petcharat K; Prommas S; Smanchat B; Bhamarapravatana K; Suwannarurk K
    Biomed Res Int; 2022; 2022():9449036. PubMed ID: 35198639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A prospective randomized study comparing misoprostol and oxytocin for premature rupture of membranes at term.
    Zeteroğlu S; Engin-Ustün Y; Ustün Y; Güvercinçi M; Sahin G; Kamaci M
    J Matern Fetal Neonatal Med; 2006 May; 19(5):283-7. PubMed ID: 16753768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controversies: prelabor rupture of the membranes at term: the case for expectant management.
    Keirse MJ; Ottervanger HP; Smit W
    J Perinat Med; 1996; 24(6):563-72. PubMed ID: 9120739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Misoprostol versus prostaglandin E2 gel for labor induction in premature rupture of membranes after 34 weeks of pregnancy.
    Zhang Y; Wang J; Yu Y; Xie C; Xiao M; Ren L
    Int J Gynaecol Obstet; 2015 Sep; 130(3):214-8. PubMed ID: 26118328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mode of delivery in pregnancies with premature rupture of membranes at or before term following induction of labor with vaginal prostaglandin E2.
    Ben-Haroush A; Yogev Y; Glickman H; Bar J; Kaplan B; Hod M
    Am J Perinatol; 2004 Jul; 21(5):263-8. PubMed ID: 15232758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of efficacy and safety of sublingual misoprostol with intracervical dinoprostone gel for cervical ripening in prelabour rupture of membranes after 34 weeks of gestation.
    Jha N; Sagili H; Jayalakshmi D; Lakshminarayanan S
    Arch Gynecol Obstet; 2015 Jan; 291(1):39-44. PubMed ID: 25055933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimal timing of labor induction after prelabor rupture of membranes at term: a secondary analysis of the TERMPROM study.
    Melamed N; Berghella V; Ananth CV; Lipworth H; Yoon EW; Barrett J
    Am J Obstet Gynecol; 2023 Mar; 228(3):326.e1-326.e13. PubMed ID: 36116523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative randomized study of oral prostaglandin E2 (PGE2) tablets and intravenous oxytocin in induction of labor in patients with premature rupture of membranes before 37 weeks of pregnancy.
    el-Qarmalawi AM; Elmardi AA; Saddik M; el-Abdel Hadi F; Shaker SM
    Int J Gynaecol Obstet; 1990 Oct; 33(2):115-9. PubMed ID: 1976543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxytocin Compared to Buccal Misoprostol for Induction of Labor after Term Prelabor Rupture of Membranes.
    Freret TS; Chacón KM; Bryant AS; Kaimal AJ; Clapp MA
    Am J Perinatol; 2021 Feb; 38(3):224-230. PubMed ID: 31491801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Labor induction by vaginal misoprostol in grand multiparous women.
    Bique C; Bugalho A; Bergström S
    Acta Obstet Gynecol Scand; 1999 Mar; 78(3):198-201. PubMed ID: 10078580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostaglandin E2 gel versus misoprostol for cervical ripening in patients with premature rupture of membranes after 34 weeks.
    Frohn WE; Simmons S; Carlan SJ
    Obstet Gynecol; 2002 Feb; 99(2):206-10. PubMed ID: 11814498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.